Almanack Investment Partners LLC. Makes New $68,000 Investment in ASP Isotopes Inc. (NASDAQ:ASPI)

Almanack Investment Partners LLC. acquired a new position in shares of ASP Isotopes Inc. (NASDAQ:ASPI) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 15,050 shares of the company’s stock, valued at approximately $68,000.

A number of other hedge funds also recently modified their holdings of ASPI. Hanson & Doremus Investment Management acquired a new position in ASP Isotopes during the fourth quarter valued at approximately $27,000. B. Riley Wealth Advisors Inc. acquired a new position in ASP Isotopes during the third quarter worth $42,000. The Manufacturers Life Insurance Company bought a new stake in ASP Isotopes during the third quarter worth about $52,000. JPMorgan Chase & Co. boosted its holdings in shares of ASP Isotopes by 31.4% in the 3rd quarter. JPMorgan Chase & Co. now owns 22,196 shares of the company’s stock valued at $62,000 after buying an additional 5,307 shares during the last quarter. Finally, KKM Financial LLC grew its position in shares of ASP Isotopes by 66.2% in the 3rd quarter. KKM Financial LLC now owns 22,600 shares of the company’s stock valued at $63,000 after acquiring an additional 9,000 shares during the period. Institutional investors own 16.80% of the company’s stock.

ASP Isotopes Stock Performance

Shares of ASPI stock opened at $6.19 on Friday. The stock has a market capitalization of $441.90 million, a PE ratio of -10.15 and a beta of 3.51. The company has a debt-to-equity ratio of 0.80, a current ratio of 7.55 and a quick ratio of 7.54. The business’s 50 day simple moving average is $5.15 and its 200 day simple moving average is $4.34. ASP Isotopes Inc. has a one year low of $1.86 and a one year high of $9.33.

Analyst Upgrades and Downgrades

Separately, Canaccord Genuity Group reissued a “buy” rating and set a $4.50 price target on shares of ASP Isotopes in a report on Friday, October 18th.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.